Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Journal of Medicinal Chemistry|September 1, 1988
Platinum complexes with binding affinity for the estrogen receptorN Knebel, E von AngererAnti-Cancer Drug Design|June 1, 1989
Platinum complexes with a selective action on estrogen receptor-positive mammary tumorsE von Angerer, H Birnböck, N KnebelArchiv Der Pharmazie|October 1, 1991
[Antitumor platinum(II) complexes with substituted 2-aminomethylpyridine ligands]H Brunner, G Nerl, E von Angerer, et al.Journal of Medicinal Chemistry|September 1, 1990
1-(aminoalkyl)-2-phenylindoles as novel pure estrogen antagonistsE von Angerer, N Knebel, M Kager, et al.European Journal of Cancer & Clinical Oncology|February 1, 1989
Carrier mediated action of platinum complexes on estrogen receptor positive tumorsN Knebel, C D Schiller, M R Schneider, et al.Current Opinion in Drug Discovery & Development|August 4, 2009
Tubulin as a target for anticancer drugsE von AngererJournal of Medicinal Chemistry|November 1, 1982
Effect of N,N'-diethyl-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines on the 7,12-dimethylbenz[a]anthracene-induced mammary carcinoma of the ratE von AngererJournal of Medicinal Chemistry|January 1, 1987
2-Phenylindoles. Effect of N-benzylation on estrogen receptor affinity, estrogenic properties, and mammary tumor inhibiting activityE von Angerer, J StrohmeierArchiv Der Pharmazie|September 1, 1990
2-phenylindole-linked nitroimidazoles as potential radiosensitizers for estrogen receptor positive tumorsS Erber, E von AngererArchiv Der Pharmazie|October 30, 1998
2-Phenylbenzo[b]thiophene-based antiestrogens with mammary tumor inhibiting activityS Leichtl, E von AngererPageof 7